Exact Mass: 426.1013628
Exact Mass Matches: 426.1013628
Found 107 metabolites which its exact mass value is equals to given mass value 426.1013628,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(-)-Epiafzelechin 3-gallate
(-)-Epiafzelechin 3-gallate is found in tea. (-)-Epiafzelechin 3-gallate is isolated from Camellia sinensis var. assamica (oolong tea). Isolated from Camellia sinensis variety assamica (oolong tea). (-)-Epiafzelechin 3-gallate is found in tea.
(3-(2-(4-(2-(Trifluoromethyl)phenoxy)piperidin-1-yl)thiazol-5-yl)-1,2,4-oxadiazol-5-yl)methanol
Lenvatinib
C21H19ClN4O4 (426.10947640000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
8-Deoxy-15-(3-hydroxy-2-methyl-propanoyl)-lactucin-3-sulfate
(-)-sanguinolignan D|(8R,7S,8S)-7-acetoxy-3,3,4,4-bis(methylenedioxy)-7-oxolignano-9,9-lactone
5,7-Diacetoxy-3-(4-acetoxy-phenyl)-6-methoxy-chromen-4-on|5,7-diacetoxy-3-(4-acetoxy-phenyl)-6-methoxy-chromen-4-one
9alpha,11-dihydroxy-13-chloro-11,13-dihydroatripliciolide-8-O-angelate
8-Me ehter,tri-Ac-1,3,5,8-Tetrahydroxy-2-methylanthraquinone
(5E,8Z,14Z)-6-iodoicosa-5,8,14,19-tetraen-11-ynoic acid
3-Carboxy-6,7-dihydroxy-1-(3,4-dihydroxyphenyl)-naphthalene-9,2-O-malic acid ester
19-Ac-(ent-4beta,7alpha,12betaH)-18-Chloro-15,16-epoxy-4,7,19-trihyrdroxy-3,6-dioxo-13(16),14-clerodadien-20,12-olide
Ala Cys Cys Met
Ala Cys Met Cys
Ala Met Cys Cys
Cys Ala Cys Met
Cys Ala Met Cys
Cys Cys Ala Met
Cys Cys Cys Val
Cys Cys Met Ala
Cys Cys Val Cys
Cys Met Ala Cys
Cys Met Cys Ala
Cys Val Cys Cys
Met Ala Cys Cys
Met Cys Ala Cys
Met Cys Cys Ala
Val Cys Cys Cys
Hexyl(triphenyl)phosphonium bromide
C24H28BrP (426.11118780000004)
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
.beta.-D-Glucopyranosiduronic acid, phenyl 1-thio-, methyl ester, triacetate
ICI 199,441 hydrochloride
ICI 199441 is a potent and selective κ-opioid receptor agonist. ICI 199441 can improve heart resistance to ischemia/reperfusion[1].
2-amino-4-(3-chlorophenyl)-6-(2-furanylmethyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester
C22H19ClN2O5 (426.09824340000006)
2-[[3-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]thio]-N-(5-methyl-3-isoxazolyl)acetamide
C19H18N6O4S (426.11101880000007)
1-[3-({[(4-Amino-5-fluoro-2-methylquinolin-3-YL)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol
(4AR,6R,7S,8R,8AR)-8-((5R,6R)-3-Carboxy-tetrahydro-4,5,6-trihydroxy-2H-pyran-2-yloxy)-hexahydro-6,7-dihydroxy-2-methylpyrano[3,2-D][1,3]dioxine-2-carboxylic acid)
Lenvatinib
C21H19ClN4O4 (426.10947640000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
methyl (2R)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
(2S)-2-[(2R,3R,4R,5S,6R)-3-[[(2R)-2-amino-3-formylsulfanylpropanoyl]amino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanedioic acid
C14H22N2O11S (426.09442620000004)
(-)-sanguinolignan D
A lignan isolated from the leaves of Piper sanguineispicum.
3-(2-chlorophenyl)-6-[3-(cyclopropylmethoxy)-4-methoxyphenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
C21H19ClN4O2S (426.09171840000005)
2-[(5-amino-1-phenacyl-1,2,4-triazol-3-yl)thio]-N-(3-cyano-4,5-dimethyl-2-thiophenyl)acetamide
2-Chloro-N-[(E)-(2-morpholin-4-yl-4-phenyl-1,3-thiazol-5-yl)methylideneamino]benzamide
C21H19ClN4O2S (426.09171840000005)
epiafzelechin 3-gallate
A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epiafzelechin.
Keto Ziprasidone
C21H19ClN4O2S (426.09171840000005)
Keto Ziprasidone is an impurity of Ziprasidone[1]. Ziprasidone, an antipsychotic agent, is a combined 5-HT (serotonin) and dopamine receptor antagonist[2].
methyl (1r,2r)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
6,6-dichloro-3-methoxy-n,5-dimethyl-n-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2z,4s,7r,8s,9s,10r,11r)-7-(chloromethyl)-7,10-dihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl (2z)-2-methylbut-2-enoate
4',5',7-triacetoxy-2'-methoxyisoflavone
{"Ingredient_id": "HBIN009982","Ingredient_name": "4',5',7-triacetoxy-2'-methoxyisoflavone","Alias": "NA","Ingredient_formula": "C22H18O9","Ingredient_Smile": "CC(=O)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC(=C(C=C3OC)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21512","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2z,4r,7s,8s,9s,10s,11s)-7-(chloromethyl)-7,10-dihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl (2e)-2-methylbut-2-enoate
7-(chloromethyl)-7,10-dihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl 2-methylbut-2-enoate
5,15,18-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12-trione
(2s)-3-{[(3as,9bs)-6-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-9-yl]methoxy}-2-methyl-3-oxopropoxysulfonic acid
(5ar,11ar)-8,9-bis(acetyloxy)-12-oxo-10,11a-dihydro-5ah-5,11-dioxatetraphen-3-yl acetate
2-(acetyloxy)-4-[7-(acetyloxy)-4-oxochromen-3-yl]-5-methoxyphenyl acetate
2-(acetyloxy)-4-(3,4-dihydroxyphenyl)-4',5,6-trihydroxy-[1,1'-biphenyl]-3-yl acetate
5-(carboxymethyl)-8-(2,6-dihydroxybenzoyl)-4-oxo-2-propylchromene-7-carboxylic acid
(2s)-3-{[(3as,9as,9bs)-6-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-9-yl]methoxy}-2-methyl-3-oxopropoxysulfonic acid
(2e,5s)-6,6-dichloro-3-methoxy-n,5-dimethyl-n-[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
(2z,4s,7r,8r,9r,11r)-7-(chloromethyl)-7-hydroxy-2-(hydroxymethyl)-11-methyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl (2z)-2-methylbut-2-enoate
3-bromo-2-hydroxy-6-[(1s,2s,5r)-5-isopropyl-2-(2-methoxy-2-oxoethyl)-2-methylcyclopentyl]-4-methylbenzoic acid
C20H27BrO5 (426.10417520000004)
2h-1,3-benzodioxol-5-yl[4-(2h-1,3-benzodioxole-5-carbonyl)-2-oxooxolan-3-yl]methyl acetate
(11s)-4-carboxy-4,17,19-trihydroxy-11-methyl-2,13-dioxo-12-oxa-6-thiatricyclo[13.4.0.0³,⁷]nonadeca-1(19),15,17-trien-6-ium-6-olate
methyl 2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
7-(chloromethyl)-7-hydroxy-2-(hydroxymethyl)-11-methyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl 2-methylbut-2-enoate
8,9-bis(acetyloxy)-12-oxo-10,11a-dihydro-5ah-5,11-dioxatetraphen-3-yl acetate
(1r,4r,5s,9s,11r,14s,15s,18s,19s)-5,15,18-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12-trione
2-[4-(3,4-dihydroxyphenyl)-7-hydroxy-6-methylnaphthalene-2-carbonyloxy]butanedioic acid
(2e,5s)-6,6-dichloro-3-methoxy-n,5-dimethyl-n-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
5-(acetyloxy)-3-[4-(acetyloxy)phenyl]-6-methoxy-4-oxochromen-7-yl acetate
5-(2-chloro-1-hydroxyethyl)-4a-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
(4ar,5r,6s)-5-[(1s)-2-chloro-1-hydroxyethyl]-4a-hydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
2-bromo-5-[(3-hydroxy-2,4,4-trimethylcyclohex-1-en-1-yl)methyl]phenazin-1-one
(2s)-2-[4-(3,4-dihydroxyphenyl)-7-hydroxy-6-methylnaphthalene-2-carbonyloxy]butanedioic acid
4-carboxy-4,17,19-trihydroxy-11-methyl-2,13-dioxo-12-oxa-6-thiatricyclo[13.4.0.0³,⁷]nonadeca-1(19),15,17-trien-6-ium-6-olate
2-bromo-5-{[4-(hydroxymethyl)-2,4-dimethylcyclohex-1-en-1-yl]methyl}phenazin-1-one
(4ar,5r,6s)-5-[(1s)-2-chloro-1-hydroxyethyl]-4a-hydroxy-6-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
3-bromo-2-hydroxy-6-[5-isopropyl-2-(2-methoxy-2-oxoethyl)-2-methylcyclopentyl]-4-methylbenzoic acid
C20H27BrO5 (426.10417520000004)